As AI accelerates across biopharma and other science-driven industries, organizations are encountering a critical bottleneck: advanced technologies fall short without proper scientific context. In a ...

Fapon Biopharma, a clinical-stage biotech company innovating therapeutic antibodies and fusion proteins, is pleased to announce its participation in the AACR Annual Meeting 2026, taking place April 19 ...

The Company’s audited consolidated financial statements for the fiscal years ended December 31, 2025 and 2024 and accompanying management discussion and analysis can be accessed by visiting the ...

Biointron, an antibody contract research organization, launched a new developability platform that helps drug developers identify manufacturing problems early, potentially saving millions by catching ...

Forlong Biotechnology, a clinical-stage biotech company focusing on developing transformative cytokine therapies for patients ...

This webinar explores an integrated approach to mAb development that embeds manufacturability, scalability, lifecycle ...

Learn how integrated development strategies, advanced technology platforms, and a robust CMC framework enable faster progression from DNA to IND and BLA.

Please provide your email address to receive an email when new articles are posted on . Data were derived from Kellam MS, et al. J Allergy Clin Immunol Pract. 2026 ...

Adults with severe asthma were more likely to discontinue biologic therapy based on nonclinical reasons than based on side effects or perceived ineffectiveness, according to data from more than 7000 ...